Shanker Iyer

Shanker Iyer

Director Director DIN 02815368
DIN 02815368 First appointment Dec 2000 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2000
Shareholding value •••• Premium profile

About Shanker Iyer

Data last updated:

Shanker Iyer was a Director at Jubilant Generics Limited (2013–2015) and Director at Atria Hydel Power Private Limited (2000–2018). The companies operate in Pharma and Environment.

DIN 02815368
Primary Designation Director
Industry Pharma
First Appointment 05 Dec 2000

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jubilant Generics Limited U24100UP2013FLC060821
Director25 Nov 20132013₹327 Cr (FY 2023)Active
Atria Hydel Power Private Limited U85110KA1999PTC024675
Director05 Dec 20001999₹11.35 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jubilant Generics Limited
Atria Hydel Power Private Limited
Premium access

Shareholding and investment profile for Shanker Iyer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanker Iyer

Shanker Iyer was first appointed on 05 Dec 2000 as Director at Atria Hydel Power Private Limited. The most recent appointment on record is 25 Nov 2013 at Jubilant Generics Limited.

Shanker Iyer held 2 earlier board appointments: Jubilant Generics Limited (Director, 25 Nov 2013 to 23 Jan 2015); Atria Hydel Power Private Limited (Director, 05 Dec 2000 to 30 Aug 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available